- Home
- INVA vs OMCL Comparison
INVA vs OMCL Comparison
Compare INVA & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- OMCL
- Stock Information
- Founded
- INVA 1996
- OMCL 1992
- Country
- INVA United States
- OMCL United States
- Employees
- INVA N/A
- OMCL N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- OMCL Computer Manufacturing
- Sector
- INVA Health Care
- OMCL Technology
- Exchange
- INVA Nasdaq
- OMCL Nasdaq
- Market Cap
- INVA 1.3B
- OMCL 1.5B
- IPO Year
- INVA 2004
- OMCL 2001
- Fundamental
- Price
- INVA $19.89
- OMCL $31.80
- Analyst Decision
- INVA Strong Buy
- OMCL Buy
- Analyst Count
- INVA 4
- OMCL 7
- Target Price
- INVA $40.25
- OMCL $46.71
- AVG Volume (30 Days)
- INVA 672.9K
- OMCL 510.0K
- Earning Date
- INVA 11-05-2025
- OMCL 10-29-2025
- Dividend Yield
- INVA N/A
- OMCL N/A
- EPS Growth
- INVA N/A
- OMCL N/A
- EPS
- INVA 0.53
- OMCL 0.49
- Revenue
- INVA $370,229,000.00
- OMCL $1,149,529,000.00
- Revenue This Year
- INVA $8.17
- OMCL $5.46
- Revenue Next Year
- INVA $12.06
- OMCL $3.75
- P/E Ratio
- INVA $37.06
- OMCL $63.73
- Revenue Growth
- INVA 12.02
- OMCL 6.39
- 52 Week Low
- INVA $16.67
- OMCL $22.66
- 52 Week High
- INVA $22.00
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- INVA 50.33
- OMCL 49.23
- Support Level
- INVA $19.24
- OMCL $31.17
- Resistance Level
- INVA $19.74
- OMCL $32.80
- Average True Range (ATR)
- INVA 0.48
- OMCL 0.98
- MACD
- INVA -0.11
- OMCL -0.22
- Stochastic Oscillator
- INVA 38.81
- OMCL 27.63
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.